19 Dec 2016 --- Ingredion Incorporated has announced that the U.S. Food and Drug Administration (FDA) has approved its a petition to communicate the relationship between high-amylose maize resistant starch and a reduced risk of Type 2 diabetes on the packages of conventional foods.
